Avidity Biosciences Inc. (RNA) Social Stream



Avidity Biosciences Inc. (RNA): $20.14

-0.51 (-2.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

AVIDITY BIOSCIENCES INC (RNA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RNA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $50 $36 $45.333 $21.38 112.03%
2021-12-10 4 $53 $50 $51 $21.38 138.54%
2022-05-10 3 $50 $50 $50 $21.38 133.86%
2022-08-10 4 $50 $29 $36 $21.38 68.38%
2022-09-28 5 $50 $27.001 $35.25 $21.38 64.87%
2022-11-09 5 $50 $27 $35.5 $21.38 66.04%
2022-12-14 6 $71 $27 $45.75 $21.38 113.99%
2023-03-01 6 $71 $27 $47.6 $21.38 122.64%

The Trend in the Analyst Price Target


RNA's average price target has moved up $3.27 over the prior 21 months.

Over the past 42 weeks, RNA's average upside potential has been 150.2%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-10 5 50 29.000 39.50 19.57 101.84%
2022-09-28 5 50 27.001 35.25 16.11 118.81%
2022-11-09 5 50 27.000 35.50 14.00 153.57%
2022-12-14 5 71 27.000 45.75 17.05 168.33%
2023-03-01 6 71 27.000 47.60 24.34 95.56%

RNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 5 1 0 0 0 6

The Trend in the Broker Recommendations


RNA's average broker recommendation rating improved by 0.08 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RNA as an investment opportunity.

  • In the context of all US stocks, AVIDITY BIOSCIENCES INC's variance in analysts' estimates is lower than -609.63% of them.
  • AVIDITY BIOSCIENCES INC's number of analysts covering the stock is higher than 274.33% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, AVIDITY BIOSCIENCES INC's average analyst price target is greater than 1102.66% of them.
  • In terms of how AVIDITY BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 479.22% of that group.

In the Pharmaceutical Products industry, GBIO, RPTX, and GLS are the three stocks most similar to AVIDITY BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

What is the outlook for RNA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7311 seconds.